All In MedTech

Device Trial Radar · NCT05797350

Paul Glaucoma Implant Versus Ahmed Glaucoma Valve in Childhood Glaucoma

Last checked: Nov 19, 2026Latest source record: Apr 4, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

24

Planned (sponsor's estimate)

Start

Sep 1, 2022

Primary completion

Jun 1, 2024

Study completion Dec 1, 2024

Sponsor

Lead sponsor
Al Watany Eye HospitalAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Moorfields Eye Hospital Centre Abu Dhabi
First posted
Apr 4, 2023

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 0 years, up to 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A randomized controlled trial comparing the efficacy and safety of Paul glaucoma implant and Ahmed glaucoma valve in refractory childhood glaucoma patients

Conditions

  • Glaucoma

Interventions

  • Glaucoma Drainage DeviceDevice

    Both the Paul glaucoma implant (PGI) and Ahmed glaucoma valve (AGV) are types of glaucoma drainage devices (GDDs) used to lower intraocular pressure in patients with refractory glaucoma. Devices will be implanted during a surgical procedure and work by diverting excess fluid from the eye to an external drainage tube, allowing the fluid to drain away from the eye and be absorbed into the surrounding tissue. This will help to lower the pressure inside the eye, which is important for preventing vision loss and other complications associated with glaucoma.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. IOP ReductionTime frame: 1 year

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Maadi eye subspeciality center

    Cairo, Egypt · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.